Ibuprofen and Oxcarbazepine Tablets Recalled: AttorneyOne Monitors and Keep Consumers Informed

On July 21, the FDA informed that one lot of Ibuprofen and one lot of Oxcarbazepine Tablets, by American Health Packaging (AHP), are recalled due to mislabeled packaging. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Ibuprofen and Oxcarbazepine Tablets by American Health Packaging Recalled

Ibuprofen and Oxcarbazepine Tablets by American Health Packaging Recalled

one lot of Ibuprofen and one lot of Oxcarbazepine Tablets, by American Health Packaging (AHP), are recalled due to mislabeled packaging.

San Diego, CA (PRWEB) July 25, 2014

AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on Ibuprofen and Oxcarbazepine Tablets.

The FDA published on July 21, that one lot of Ibuprofen and one lot of Oxcarbazepine Tablets, by American Health Packaging (AHP), are recalled due to mislabeled packaging. Oxcarbazepine is used for the treatment of certain types of seizures in patients with epilepsy.

The reason for the recall is that Lot #142588, Expiration Date, 01/2016 of Ibuprofen Tablets, USP, 600 mg, in a hospital unit dose presentation may contain individual blistered doses labeled as Oxcarbazepine Tablets, 300 mg, lot #142544. Lot #142544 of Oxcarbazepine Tablets, 300 mg, is also recalled. This mislabeling can cause patients receiving ibuprofen and missing their scheduled dose of oxcarbazepine; this may lead to increased chances of having a seizure. Moreover, if ibuprofen is taken in cases where it is contraindicated it may cause adverse reactions.

Taking into consideration the latest developments, AttorneyOne.com monitor daily and update the website providing accurate information on all relevant FDA safety alerts. Sean Burke, director of Media Relations at AttorneyOne.com, adds, “We are determined to keep an eye on FDA announcements concerning Ibuprofen and Oxcarbazepine Tablets and inform the public. For that reason," he continues, "our focus should squarely fall on investigating these safety alerts and getting the word out.”

According to the announcement, “Notification of the recall has been sent to distributors who received the affected product with instructions on how to notify their customers. And the FDA adds “Consumers who have received the recalled product should immediately discontinue use and contact GENCO Pharmaceutical Services.”

AttorneyOne.com has further information on Ibuprofen and Oxcarbazepine Tablets at the website including latest major drug, food, and medical products law news.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2014/07/prweb12042067.htm.